A carregar...

Adoption of Injectable Naltrexone in U.S. Substance Use Disorder Treatment Programs

OBJECTIVE: Medication-assisted treatment for substance use disorders (SUDs) is not widely used in treatment programs. The aims of the current study were to document the prevalence of adoption and implementation of extended-release injectable naltrexone, the newest U.S. Food and Drug Administration–a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Stud Alcohol Drugs
Main Authors: Aletraris, Lydia, Edmond, Mary Bond, Roman, Paul M
Formato: Artigo
Idioma:Inglês
Publicado em: Rutgers University 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4263776/
https://ncbi.nlm.nih.gov/pubmed/25486403
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!